Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
2015 · Orphanet Journal of Rare Diseases · 132 citations
https://doi.org/10.1186/s13023-015-0228-7
L
Luca Semerano
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
167
Papers
4.5K
Citations
31
h-index
59
i10-index
Luca Semerano is an academic researcher from Inserm. The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Systemic Lupus Erythematosus Research & Autoimmune and Inflammatory Disorders Research. The author has an h-index of 31, co-authored 142 publications.
Papers by this author
worksCachexia and adiposity in rheumatoid arthritis. Relevance for disease management and clinical outcomes
2015 · Joint Bone Spine · 86 citations
https://doi.org/10.1016/j.jbspin.2015.04.010
Air pollution as a determinant of rheumatoid arthritis
2018 · Joint Bone Spine · 78 citations
https://doi.org/10.1016/j.jbspin.2018.03.001
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
2023 · Genome Medicine · 77 citations
https://doi.org/10.1186/s13073-023-01173-8
Dietary recommendations of the French Society for Rheumatology for patients with chronic inflammatory rheumatic diseases
2021 · Joint Bone Spine · 66 citations
https://doi.org/10.1016/j.jbspin.2021.105319
Active immunization to tumor necrosis factor-α is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis
2009 · Arthritis Research & Therapy · 28 citations
https://doi.org/10.1186/ar2897
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat